RegeneRx Biopharmaceuticals RGRX Stock
RegeneRx Biopharmaceuticals Price Chart
RegeneRx Biopharmaceuticals RGRX Financial and Trading Overview
| RegeneRx Biopharmaceuticals stock price | 0.05 USD |
| Previous Close | 0.03 USD |
| Open | 0.03 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.03 - 0.03 USD |
| 52 Week Range | 0.01 - 0.2 USD |
| Volume | 20.28K USD |
| Avg. Volume | 148.86K USD |
| Market Cap | 4.38M USD |
| Beta (5Y Monthly) | 0.505281 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.97 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
RGRX Valuation Measures
| Enterprise Value | 5.7M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.0500002 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 57.038498 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 74.25 |
| Enterprise Value/EBITDA | N/A |
Trading Information
RegeneRx Biopharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.505281 |
| 52-Week Change | -83.33% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.2 USD |
| 52 Week Low | 0.01 USD |
| 50-Day Moving Average | 0.05 USD |
| 200-Day Moving Average | 0.12 USD |
RGRX Share Statistics
| Avg. Volume (3 month) | 148.86K USD |
| Avg. Daily Volume (10-Days) | 195.49K USD |
| Shares Outstanding | 143.55M |
| Float | 113.58M |
| Short Ratio | 0.15 |
| % Held by Insiders | 45.92% |
| % Held by Institutions | 0.0069% |
| Shares Short | 19.19K |
| Short % of Float | 0.050% |
| Short % of Shares Outstanding | 0.029% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1775.74% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -148.50% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 76.76K USD |
| Revenue Per Share (ttm) | 0.001 USD |
| Quarterly Revenue Growth (yoy) | 0% |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -1688590 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 101.56K USD |
| Total Cash Per Share (mrq) | 0.001 USD |
| Total Debt (mrq) | 1.49M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.068 |
| Book Value Per Share (mrq) | -0.026 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -823747 USD |
| Levered Free Cash Flow (ttm) | -355278 USD |
Profile of RegeneRx Biopharmaceuticals
| Country | United States |
| State | MD |
| City | Rockville |
| Address | 15245 Shady Grove Road |
| ZIP | 20850 |
| Phone | 301-208-9191 |
| Website | https://www.regenerx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 2 |
RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, Thymosin beta 4, for tissue and organ protection, repair, and regeneration. The company is developing RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease, or other pathology; RGN-352, an injectable formulation for the treatment of cardiovascular diseases, central and peripheral nervous system diseases, and other medical indications; and RGN-137, a topical gel for the treatment of dermal wounds and reduction of scar tissue. It has strategic partnerships with Lee's Pharmaceutical Group and HLB Therapeutics. The company was formerly known as Alpha 1 Biomedicals, Inc. and changed its name to RegeneRx Biopharmaceuticals, Inc. in 2000. RegeneRx Biopharmaceuticals, Inc. was incorporated in 1982 and is based in Rockville, Maryland.
Q&A For RegeneRx Biopharmaceuticals Stock
What is a current RGRX stock price?
RegeneRx Biopharmaceuticals RGRX stock price today per share is 0.05 USD.
How to purchase RegeneRx Biopharmaceuticals stock?
You can buy RGRX shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for RegeneRx Biopharmaceuticals?
The stock symbol or ticker of RegeneRx Biopharmaceuticals is RGRX.
Which industry does the RegeneRx Biopharmaceuticals company belong to?
The RegeneRx Biopharmaceuticals industry is Biotechnology.
How many shares does RegeneRx Biopharmaceuticals have in circulation?
The max supply of RegeneRx Biopharmaceuticals shares is 1.5M.
What is RegeneRx Biopharmaceuticals Price to Earnings Ratio (PE Ratio)?
RegeneRx Biopharmaceuticals PE Ratio is now.
What was RegeneRx Biopharmaceuticals earnings per share over the trailing 12 months (TTM)?
RegeneRx Biopharmaceuticals EPS is -0.97 USD over the trailing 12 months.
Which sector does the RegeneRx Biopharmaceuticals company belong to?
The RegeneRx Biopharmaceuticals sector is Healthcare.